NEW YORK (GenomeWeb) – Takara Bio USA Holdings will acquire instruments manufacturer WaferGen Biosystems, the companies announced today.

Under the terms of the deal, Takara Bio USA — formerly known as Clontech Laboratories and now a subsidiary of life science company Takara Bio — will pay an aggregate cash price based on a multiple of WaferGen's 2016 calendar year revenues, capped at $50 million. The multiple will be between one and three-and-a-half times WaferGen's full year 2016 revenues — if revenues exceed $9 million, the multiple will be capped at three-and-a-half times.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.